• Andrews and Wood have made innovation and transformation accessible, understandable and doable. An inspirational and entertaining read, full of timeless insights into transformation and success.

    Sandra Harding

Peter AndrewsPeter Andrews

Professor Andrews received his PhD from the University of Melbourne in 1969 for a thesis on the relationship between the chemical structure and biological activity of anticonvulsant drugs. He has since led multidisciplinary scientific teams at several Australian universities, including Queensland’s Institute for Molecular Bioscience – the first of several world-class biomedical research institutes established under the Queensland government’s Smart State Strategy – which he co-founded and directed with Professor John Mattick AO.

From 2003 to 2010 he served as Queensland’s first Chief Scientist and was inaugural chairman of both the Standing Committee of the Premier’s Smart State Council and the Queensland R&D Council.

He has been at the forefront of the development of the Australian biotechnology industry as co-founder and board member of half a dozen scientific firms, including ASX listed companies Biota and Alchemia, both of which have drugs on international markets.  He is currently chairman of Implicit Bioscience, a private company with two potential drugs in development, and a Professor Emeritus at the University of Queensland.

He is a Fellow of the Australian Academy of Technological Sciences and Engineering, the Australian Institute of Company Directors, and the Royal Australian Chemical Institute, and a member of the Ernst & Young Entrepreneur of The Year Winners’ Network. In 2004 he was appointed an Officer of the Order of Australia.

He has served as President of the Asian Federation of Medicinal Chemistry, Chairman of the Australian Institute of Marine Science, and Chairman of Troplinks, a public sector organisation devoted to building bridges between Australian research and industry and nations of the tropical world.

Professor Andrews has consulted widely to the pharmaceutical industry in Europe, Japan and the United States, and to universities, venture capital firms, and government agencies in Australia and New Zealand.

Contact Peter

Discover the ten vital characteristics of überpreneurs